Royal Marsden Hospital Surrey

Sutton SM25PT

2 studies enrolling now · 8 studies all time

What they study most

Advanced Prostate Cancer, BAP1 Loss of Function, Bladder Carcinoma in Situ (CIS), Breast Cancer, Gastric Adenocarcinoma, Gastric Cancer, Melanoma, Mesothelioma, Metastatic Prostate Cancer, Small Cell Lung Cancer and Breast Cancer, Solid Tumor, Urothelial Carcinoma

Studies at this site

• A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors — Recruiting now
• A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer — Recruiting now
• Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) — Running, not enrolling
• Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer — Completed
• Evaluate the Safety, Tolerability, Biodistribution and Anti Tumour Activity of 177LU-OPS201 With Companion Imaging 68Ga-OPS202 PET/CT in Previously Treated Subjects With Locally Advanced or Metastatic Cancers Expressing Somatostatin Receptor 2 (SSTR2) — Stopped early
• A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer — Completed
• An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma — Completed
• Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma — Completed